Hepatitis A, B, and C

John Christenson, John J. Manaloor

Research output: Contribution to journalArticle


• On the basis of strong epidemiologic evidence, hepatitis viruses are responsible for significant morbidity and mortality in young infants and children throughout the world. (1)(22)(33) • On the basis of research evidence, hepatitis A and B vaccines are effective in preventing disease. Furthermore, data strongly demonstrate that hepatitis A and B vaccines are safe in young infants and children. (23)(24)(26)(34) • On the basis of strong evidence, pregnant mothers should be screened and concomitant active and passive immunization against hepatitis B should be provided to newborns as a strategy to prevent chronic hepatitis B in children. (44)(47) • On the basis of new research, the use of antiviral agents is beneficial in the treatment of and potential clearance of chronic infections caused by hepatitis B and C viruses. (54)(55)(57)(58).

Original languageEnglish (US)
Pages (from-to)426-438
Number of pages13
JournalPediatrics in Review
Issue number10
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Hepatitis A, B, and C'. Together they form a unique fingerprint.

  • Cite this